Franziska Eckardt
5PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Nov 27, 2025
High-Dose 8 mg Aflibercept for Neovascular Age-Related Macular Degeneration: Who Is Being Treated with This New Agent?Caspar Liesenhoff, Carolin Meyrl, Daniel Krause
|Oct 29, 2025
Extended Real-World Efficacy of Faricimab in Therapy-Resistant Macular Edema Due to Retinal Vein Occlusion: 9-Month Follow-Up Results.Michael Hafner, Tina R Herold, Alexander Kufner
|Jul 31, 2025
Efficacy of switching treatment to faricimab in recalcitrant neovascular age related macular degeneration - 6 month results after completion of the loading phase.Franziska Eckardt, Michael Hafner, Anna Lorger
|Apr 12, 2025
Switching to Faricimab in Therapy-Resistant Macular Edema Due to Retinal Vein Occlusion: Initial Real-World Efficacy Outcomes.Michael Hafner, Tina R Herold, Alexander Kufner
Pageof 1